Cumulative Irritation Test
Completed · Phase 1
Conditions studied: Onychomycosis
In brief
The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
Key facts
- Study ID
- NCT00680095
- Run by
- Pfizer
- People needed
- 37
- Starts
- 2007-01-22
- Expected to finish
- 2007-02-19
- Last updated by the study team
- 2019-04-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy, volunteers of either sex, at least 18 years of age or older
- Females of childbearing potential submitted to a urine pregnancy test and had negative results at Day 1 and at the final visit and also was using an effective method of birth control (e.g. abstinence, implants, injectables, oral contraceptives, intrauterine contraceptive devices or double barrier) or agreed to use an effective method of birth control prior to becoming sexual active
- Subjects were of any skin type or race providing their degree of pigmentation did not interfere with making readings of skin reactions
- Subjects were willing to follow the study procedures and complete the study
- Written informed consent was obtained
You may not qualify if…
- Subject with any skin disease that would have in any way confounded interpretation of the study results. Atopic dermatitis/eczema, psoriasis or chronic asthma were excluded
- Subject was pregnant or nursing
- Subject had a history of sensitivity to any component of any of the formulations
- Use of chronic medications (such as antihistamines, corticosteroids, analgesics and anti-inflammatories) for one week before and during the study
Where it is running
- The Education and Research Foundation, Inc. — Lynchburg, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.